Allergy/Immunology - Hematology/Oncology News & Articles

1 Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men - A cross-sectional study Cytokine, May 17, 2013    Clinical Article

2 At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy Journal of Leukocyte Biology, May 16, 2013    Review Article

3 The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas Journal of Neuroimmunology, May 16, 2013    Clinical Article

4 Immunohistochemical detection of SATB1 is independent of thyroid cancer differentiation The Laryngoscope, May 15, 2013    Clinical Article

5 Toll-like receptor-associated sequence variants and prostate cancer risk among men of African descent Genes and Immunity, May 15, 2013    Clinical Article

6 MyD88 and its divergent toll in carcinogenesis Trends in Immunology, May 15, 2013    Review Article

7 Modeling the impact of quadrivalent HPV vaccination on the incidence of Pap test abnormalities in the United States Vaccine , May 14, 2013    Clinical Article

8 Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of undetermined significance Blood Coagulation & Fibrinolysis, May 14, 2013    Clinical Article

9 Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells Cancer Immunology, Immunotherapy, May 14, 2013    Clinical Article

10 The immunomodulatory and anticancer properties of propolis Clinical Reviews in Allergy and Immunology, May 14, 2013    Review Article

11 Tumour heterogeneity and immune-modulation Current Opinion in Pharmacology , May 14, 2013    Review Article

12 miR-142-3p Is Involved in CD25+ CD4 T Cell Proliferation by Targeting the Expression of Glycoprotein A Repetitions Predominant The Journal of Immunology, May 14, 2013    Review Article

13 External quality assessment of human neutrophil antigen (HNA)-specific antibody detection and HNA genotyping from 2000 to 2012 Vox Sanguinis, May 14, 2013    Clinical Article

14 Antitumor effects and mechanisms of dendritic cells stimulated by sCD40L on ovarian cancer cells Full Text OncoTargets and Therapy, May 14, 2013    Clinical Article

15 Novel Immunotherapeutic Strategies in Development for Renal Cell Carcinoma Full Text European Urology, May 13, 2013    Review Article

16 Targeting IL-15 in large granular lymphocyte leukemia Expert Review of Clinical Immunology, May 13, 2013    Review Article

17 Phase I Study of U3-1287, a Fully Human Anti-HER3 Monoclonal Antibody, in Patients with Advanced Solid Tumors Clinical Cancer Research, May 13, 2013    Clinical Article

18 Absence of CCL2 is sufficient to restore hippocampal neurogenesis following cranial irradiation Brain, Behavior, and Immunity, May 13, 2013    Clinical Article

19 NKG2D CAR T-cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors Immunology & Cell Biology, May 13, 2013    Review Article

20 Sensitivity of assays for the detection of HPA-1a antibodies: results of an international workshop demonstrating the impact of cation chelation from integrin αIIbβ3 on three widely used assays Vox Sanguinis, May 13, 2013    Clinical Article

1 Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: Involvement of the HER/PI3K/Akt/mTOR and IAP pathways Clinical Cancer Research, April 29, 2013

2 RNA pulsed dendritic cells: An approach for cancer immunotherapy Vaccine , February 21, 2013    Review Article

3 MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models Cancer Research, April 25, 2013

4 Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients Investigational New Drugs, April 10, 2013

5 Human cancer regression antigens Current Opinion in Immunology, April 9, 2013

6 Product-dependent anti-factor VIII antibodies Haemophilia, April 24, 2013

7 Liposome-Coupled Anti-CD137 + IL-2 for Nontoxic Tumor Immunotherapy Cancer Research, March 11, 2013

8 Combining cancer immunotherapy and targeted therapy Current Opinion in Immunology, April 5, 2013

9 Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy Cancer Research, April 19, 2013

10 Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine Cancer Immunology, Immunotherapy, April 26, 2013    Review Article

11 Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settings Cancer Research, April 11, 2013    Review Article

12 Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: Frameshift peptides for treating MSI+ blood cancers European Journal of Cancer, April 8, 2013

13 NK cells - Versatile tools for viral defense and cancer treatment European Journal of Immunology, April 22, 2013

14 Elevated level of peripheral CD8+CD28 -T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy Cancer Immunology, Immunotherapy, April 22, 2013

15 Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy Cancer Immunology, Immunotherapy, April 12, 2013

16 Association between allergies, asthma, and breast cancer risk among women in Ontario, Canada Cancer Causes and Control, April 25, 2013

17 Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies Frontiers in Immunology, April 11, 2013    Review Article

18 Targeting uPAR with Antagonistic Recombinant Human Antibodies in Aggressive Breast Cancer Cancer Research, April 1, 2013

19 Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy Journal of Cancer Research & Clinical Oncology, April 16, 2013

20 Modulating T regulatory cells in cancer: how close are we Immunology & Cell Biology, April 18, 2013    Review Article